- United Kingdom
- United States
- South Africa
- Aland Islands
- American Samoa
- Antigua and Barbuda
- Bosnia and Herzegovina
- Bouvet Island
- British Indian Ocean Territory
- British Virgin Islands
- Burkina Faso
- Cape Verde
- Cayman Islands
- Central African Republic
- Christmas Island
- Cocos (Keeling) Islands
- Congo (Brazzaville)
- Congo (Kinshasa)
- Cook Islands
- Costa Rica
- Czech Republic
- Dominican Republic
- El Salvador
- Equatorial Guinea
- Falkland Islands
- Faroe Islands
- French Guiana
- French Polynesia
- French Southern Territories
- Heard Island and McDonald Islands
- Hong Kong S.A.R., China
- Isle of Man
- Ivory Coast
- Macao S.A.R., China
- Marshall Islands
- Netherlands Antilles
- New Caledonia
- New Zealand
- Norfolk Island
- Northern Mariana Islands
- North Korea
- Palestinian Territory
- Papua New Guinea
- Puerto Rico
- Saint Barthélemy
- Saint Helena
- Saint Kitts and Nevis
- Saint Lucia
- Saint Martin (French part)
- Saint Pierre and Miquelon
- Saint Vincent and the Grenadines
- San Marino
- Sao Tome and Principe
- Saudi Arabia
- Sierra Leone
- Solomon Islands
- South Georgia and the South Sandwich Islands
- South Korea
- Sri Lanka
- Svalbard and Jan Mayen
- Trinidad and Tobago
- Turks and Caicos Islands
- U.S. Virgin Islands
- United Arab Emirates
- United States Minor Outlying Islands
- Wallis and Futuna
- Western Sahara
The Nomination Committee meets when required and comprises Duncan Nichol (Chairman) and the Non-Executive Directors Constance Baroudel, Jeff Harris and Bruce Edwards. Only members of the Committee are entitled to be present at meetings but others may be invited by the Committee to attend if appropriate.
The Nomination Committee is responsible for considering all potential appointments to the Board and for making suitable proposals to the Board in relation to potential appointments. It meets as and when appointments to the Board or other senior positions within the Group are made.
The Board has agreed formal, rigorous and transparent procedures to be followed by the Committee in making its recommendations and appointments to the Board. The Committee has access to such information and advice both within the Group and externally, at the cost of the Company, as it considers necessary. This may include the appointment of external executive search consultants where considered appropriate. The Committee met twice during the year.
The Nomination Committee reviews the senior leadership needs of the Group to enable it to compete effectively in the market place. The Nomination Committee also advises the Board on succession planning for executive Board appointments although the Board is itself responsible for succession generally.
The Group Company Secretary acts as Secretary to all Board Committees.
Terms of reference
1.1 The Committee shall comprise at least three Directors. A majority of the members of the Committee shall be independent Non-Executive Directors.
1.2 Only members of the Committee have the right to attend Committee meetings. However, other individuals such as the Chief Executive, the Head of Human Resources and external advisers may be invited to attend for all or part of any meeting, as and when appropriate and necessary.
1.3 Appointments to the Committee are made by the Board and shall be for a period of up to three years, which may be extended for further periods of up to three-years, provided the Director still meets the criteria for membership of the Committee.
1.4 The Board shall appoint the Committee Chairman who should be either the Chairman of the Board or an independent Non-Executive Director. In the absence of the Committee Chairman and/or an appointed deputy, the remaining members present shall elect one of themselves to chair the meeting from those who would qualify under these terms of reference to be appointed to that position by the Board. The Chairman of the Board shall not chair the Committee when it is dealing with the matter of succession to the chairmanship.
The Company Secretary or his or her nominee shall act as the Secretary of the Committee.
The quorum necessary for the transaction of business shall be two, both of whom must be independent Non-Executive Directors.
4 Frequency of meetings
The Committee shall meet at least twice a year and otherwise as required.
5 Notice of meetings
5.1 Meetings of the Committee shall be called by the Secretary of the Committee at the request of the Committee Chairman.
5.2 Unless otherwise agreed, notice of each meeting confirming the venue, time and date together with an agenda of items to be discussed, shall be forwarded to each member of the Committee, any other person required to attend and all other Non-Executive Directors, no later than three working days before the date of the meeting. Supporting papers shall be sent to Committee members and to other attendees as appropriate, at the same time.
6. Minutes of meetings
6.1 The Secretary shall minute the proceedings and resolutions of all Committee meetings, including the names of those present and in attendance.
6.2 Draft minutes of Committee meetings shall be circulated promptly to all members of the Committee. Once approved, minutes should be circulated to all other members of the Board unless it would be inappropriate to do so.
7 Annual general meeting
The Committee Chairman should attend the Annual General Meeting to answer any shareholder questions on the Committee’s activities.
The Committee should carry out the duties below for the parent company, major subsidiary undertakings and the Group as a whole, as appropriate.
The Committee shall
8.1 regularly review the structure, size and composition (including the skills, knowledge, experience and diversity) of the Board and make recommendations to the Board with regard to any changes.
8.2 give full consideration to succession planning for Directors and other Senior Executives in the course of its work, taking into account the challenges and opportunities facing the Company, and the skills and expertise needed on the Board in the future.
8.3 keep under review the leadership needs of the organisation, both Executive and Non-Executive, with a view to ensuring the continued ability of the organisation to compete effectively in the marketplace.
8.4 keep up to date and fully informed about strategic issues and commercial changes affecting the Company and the market in which it operates.
8.5 be responsible for identifying and nominating for the approval of the Board, candidates to fill Board vacancies as and when they arise.
8.6 before any appointment is made by the Board, evaluate the balance of skills, knowledge, experience and diversity on the Board, and, in the light of this evaluation prepare a description of the role and capabilities required for a particular appointment. In identifying suitable candidates the Committee shall
8.6.1 use open advertising or the services of external advisers to facilitate the search.
8.6.2 consider candidates from a wide range of backgrounds, and
8.6.3 consider candidates on merit and against objective criteria and with due regard for the benefits of diversity on the board, including gender, taking care that appointees have enough time available to devote to the position.
8.7 for the appointment of a Chairman, the Committee should prepare a job specification, including the time commitment expected. A proposed Chairman’s other significant commitments should be disclosed to the Board before appointment and any changes to the Chairman’s commitments should be reported to the Board as they arise.
8.8 prior to the appointment of a Director, the proposed appointee should be required to disclose any other business interests that may result in a conflict of interest and be required to report any future business interests that could result in a conflict of interest.
8.9 ensure that on appointment to the Board, Non-Executive Directors receive a formal letter of appointment setting out clearly what is expected of them in terms of time commitment, committee service and involvement outside Board meetings.
8.10 review the results of the Board performance evaluation process that relate to the composition of the Board.
8.11 review annually the time required from Non-Executive Directors. Performance evaluation should be used to assess whether the Non-Executive Directors are spending enough time to fulfil their duties, and
8.12 work and liaise as necessary with all other Board Committees.
The Committee shall also make recommendations to the Board concerning
8.13 formulating plans for succession for both Executive and Non-Executive Directors in particular for the key roles of Chairman and Chief Executive.
8.14 suitable candidates for the role of Senior Independent Director.
8.15 membership of the Audit and Remuneration Committees, and any other Board Committees as appropriate, in consultation with the Chairmen of those Committees.
8.16 the reappointment of any Non-Executive Director at the conclusion of their specified term of office having given due regard to their performance and ability to continue to contribute to the Board in the light of the knowledge, skills and experience required.
8.17 the re-election by shareholders of Directors under the annual re-election provisions of the UK Corporate Governance Code (“the Code”) or the retirement by rotation provisions in the Company’s Articles of Association, having due regard to their performance and ability to continue to contribute to the Board in the light of the knowledge, skills and experience required and the need for progressive refreshing of the Board (particularly in relation to Directors being re-elected for a term beyond six years).
8.18 any matters relating to the continuation in office of any Director at any time including the suspension or termination of service of an Executive Director as an employee of the Company subject to the provisions of the law and their service contract, and
8.19 the appointment of any Director to Executive or other office.
9 Reporting responsibilities
9.1 The Committee Chairman shall report to the Board on its proceedings after each meeting on all matters within its duties and responsibilities.
9.2 The Committee shall make whatever recommendations to the Board it deems appropriate on any area within its remit where action or improvement is needed.
9.3 The Committee shall produce a report to be included in the Company’s Annual Report about its activities, the process used to make appointments and explain if external advice or open advertising has not been used. (Where an external search agency has been used, it shall be identified in the Annual Report and a statement made as to whether it has any connection with the Company.)
9.4 The report referred to in 9.3 above should include a statement of the Board’s policy on diversity, including gender, any measurable objectives that it has set for implementing the policy, and progress on achieving the objectives.
10 Other matters
The Committee shall
10.1 have access to sufficient resources in order to carry out its duties, including access to the Company Secretary for assistance as required.
10.2 be provided with appropriate and timely training, both in the form of an induction programme for new members and on an ongoing basis for all members.
10.3 give due consideration to laws and regulations, the provisions of the Code and the requirements of the UK Listing Authority’s Listing, Prospectus and Disclosure and Transparency Rules and any other applicable Rules, as appropriate, and
10.4 arrange for periodic reviews of its own performance and, at least annually, review its constitution and terms of reference to ensure it is operating at maximum effectiveness and recommend any changes it considers necessary to the Board for approval.
The Committee is authorised by the Board to obtain, at the Company’s expense, outside legal or other professional advice on any matters within its terms of reference.
You are contacting:
Synergy Health Europe/Middle East Head Office
Synergy Health Nederland B.V., Fokkerstraat 574
3125 BE Schiedam, The Netherlands
Postbus 109, 3100 AC
Schiedam, The Netherlands